XML 47 R33.htm IDEA: XBRL DOCUMENT v3.26.1
GOODWILL AND INTANGIBLE ASSETS (Tables)
 6 Months Ended
Jun. 30, 2026
Intangible Asset, Goodwill and Other [Abstract]  
Schedule of Intangible Assets
Intangible assets, net, consists of in-process research and development, or IPR&D, from the GQ Bio Acquisition and Flexion Acquisition, developed technology from the Flexion Acquisition and MyoScience Acquisition and customer relationships from the MyoScience Acquisition. In June 2026, $53.2 million, net, of developed technologies and a nominal amount of customer relationships related to iovera° from the MyoScience Acquisition were reclassified to assets held for sale in conjunction with entering into the Purchase Agreement with Zimmer. Amortization on these intangible assets ceased being recorded at the time the assets were classified as held for sale. For more information, see Note 3, Assets and Liabilities Held for Sale.
Intangible assets, net, as of June 30, 2026 are summarized as follows (dollar amounts in thousands):
June 30, 2026Gross Carrying ValueAccumulated AmortizationIntangible Assets, NetWeighted-Average Useful Lives
Developed technologies$480,000 $(228,085)$251,915 9 years, 9 months
Acquired IPR&D (1)
33,569 — 33,569 
     Total intangible assets, net$513,569 $(228,085)$285,484 
(1) The change in the gross carrying value compared to December 31, 2025 reflects the impact of foreign currency translation adjustments related to the IPR&D acquired from the GQ Bio Acquisition.
December 31, 2025Gross Carrying ValueAccumulated AmortizationIntangible Assets, NetWeighted-Average Useful Lives
Developed technologies$590,000 $(256,213)$333,787 10 years, 5 months
Customer relationships90 (61)29 10 years
Total finite-lived intangible assets, net590,090 (256,274)333,816 
Acquired IPR&D34,284 — 34,284 
     Total intangible assets, net$624,374 $(256,274)$368,100